Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intravascular osmotic gradient is the difference in osmotic (solute) concentration across the vascular wall, typically between blood plasma (intravascular compartment) and the surrounding interstitial fluid[2][4][5][6][7]. This gradient is primarily caused by plasma proteins (notably albumin) that do not pass through typical capillary walls and thus draw water into the vascular space[2][6][7]. It is a key determinant of fluid distribution, Starling forces, and capillary exchange, influencing whether water moves into or out of the bloodstream[2][4][5][7]. This gradient is not a molecule or receptor but a physiological principle often manipulated therapeutically (e.g., in osmotherapy for cerebral edema via agents such as mannitol) or implicated in pathologies like edema, hypovolemia, or dehydration[9].
Create or adjust osmotic gradient to move water between compartments
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intravascular osmotic gradient.